Susquehanna International Group
OCAT

Susquehanna International Group’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Susquehanna International Group’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,200
Closed -$153K – 10309
2015
Q4 		$153K Sell
18,200
-39,800
-69% -$266K ﹤0.01% 8644
2015
Q3 		$242K Buy
58,000
+14,100
+32% +$61.6K ﹤0.01% 8402
2015
Q2 		$231K Buy
43,900
+30,900
+238% +$198K ﹤0.01% 9047
2015
Q1 		$80K Buy
+13,000
New +$83.3K ﹤0.01% 9037

Susquehanna International Group's OCAT Position: Q1 2016 in Review

Susquehanna International Group sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 78,364 shares — an estimated $659K sold.

Susquehanna International Group first reported a position in OCAT in Q1 2015 and held it in 4 quarters. The position peaked at $659K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Susquehanna International Group reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Susquehanna International Group sold 78,364 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $659K.
  • Susquehanna International Group first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q1 2015 and held it in 4 quarters.
  • Susquehanna International Group's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $659K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Susquehanna International Group's 13F filing for Q1 2016, filed 13 May 2016.